Literature DB >> 21493923

The PPAR-RXR transcriptional complex in the vasculature: energy in the balance.

Jorge Plutzky1.   

Abstract

The peroxisome proliferator-activated receptors (PPARs) and the retinoid X receptors (RXRs) are ligand-activated transcription factors that coordinately regulate gene expression. This PPAR-RXR transcriptional complex plays a critical role in energy balance, including triglyceride metabolism, fatty acid handling and storage, and glucose homeostasis: processes whose dysregulation characterize obesity, diabetes, and atherosclerosis. PPARs and RXRs are also involved directly in inflammatory and vascular responses in endothelial and vascular smooth muscle cells. New insights into fundamental aspects of PPAR and RXR biology, and their actions in the vasculature, continue to appear. Although RXRs are obligate heterodimeric partners for PPAR action, the part that RXRs, and their endogenous retinoid mediators, exert in the vessel wall is less well understood. Biological insights into PPAR-RXRs may help inform interpretation of clinical trials with synthetic PPAR agonists and prospects for future PPAR therapeutics. Importantly, the extensive data establishing a key role for PPARs and RXRs in energy balance, inflammation, and vascular biology stands separately from the clinical experience with any given synthetic PPAR agonist. Both the basic science data and the clinical experience with PPAR agonists identify the need to better understand these important transcriptional regulators.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493923     DOI: 10.1161/CIRCRESAHA.110.226860

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  54 in total

Review 1.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

2.  Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis.

Authors:  P Escudero; A Navarro; C Ferrando; E Furio; H Gonzalez-Navarro; M Juez; M J Sanz; L Piqueras
Journal:  Br J Pharmacol       Date:  2015-03-26       Impact factor: 8.739

Review 3.  Role of lipotoxicity in endothelial dysfunction.

Authors:  Jeong-a Kim; Monica Montagnani; Sruti Chandrasekran; Michael J Quon
Journal:  Heart Fail Clin       Date:  2012-08-10       Impact factor: 3.179

4.  DNA methylation is altered in maternal blood vessels of women with preeclampsia.

Authors:  Ahmad A Mousa; Kellie J Archer; Renato Cappello; Guadalupe Estrada-Gutierrez; Christine R Isaacs; Jerome F Strauss; Scott W Walsh
Journal:  Reprod Sci       Date:  2012-08-17       Impact factor: 3.060

5.  Transcriptomic and microRNA analyses of gene networks regulated by eicosapentaenoic acid in brown adipose tissue of diet-induced obese mice.

Authors:  Mandana Pahlavani; Nadeeja N Wijayatunga; Nishan S Kalupahana; Latha Ramalingam; Preethi H Gunaratne; Cristian Coarfa; Kimal Rajapakshe; Pratibha Kottapalli; Naima Moustaid-Moussa
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-09-25       Impact factor: 4.698

Review 6.  The metabolic control of schistosome egg production.

Authors:  Edward J Pearce; Stanley Ching-Cheng Huang
Journal:  Cell Microbiol       Date:  2015-04-30       Impact factor: 3.715

7.  Identification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by statins and antimalarial agents.

Authors:  Nhat-Tu Le; Yuichiro Takei; Yuki Izawa-Ishizawa; Kyung-Sun Heo; Hakjoo Lee; Alan V Smrcka; Benjamin L Miller; Kyung Ae Ko; Sara Ture; Craig Morrell; Keigi Fujiwara; Masashi Akaike; Jun-ichi Abe
Journal:  J Immunol       Date:  2014-09-03       Impact factor: 5.422

8.  Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation.

Authors:  T Michael De Silva; Mary L Modrick; Pimonrat Ketsawatsomkron; Cynthia Lynch; Yi Chu; Christopher J Pelham; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

9.  [Activation of PPARγ pathway enhances cellular anti-oxidant capacity to protect long-term cultured primary rat neural cells from apoptosis].

Authors:  Huqing Wang; Jiaxin Fan; Wanying Chen; Zhen Gao; Guilian Zhang; Haiqin Wu; Xiaorui Yu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

Review 10.  The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.

Authors:  Wai San Cheang; Xiao Yu Tian; Wing Tak Wong; Yu Huang
Journal:  Br J Pharmacol       Date:  2015-01-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.